Clover Health Investments Revenue 2020-2024 | CLOV
Clover Health Investments revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Clover Health Investments Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $2,034 |
| 2022 | $3,477 |
| 2021 | $1,472 |
| 2020 | $673 |
| 2019 | $462 |
| Clover Health Investments Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $347 |
| 2023-12-31 | $716 |
| 2023-09-30 | $482 |
| 2023-06-30 | $514 |
| 2023-03-31 | $322 |
| 2022-12-31 | $899 |
| 2022-09-30 | $857 |
| 2022-06-30 | $847 |
| 2022-03-31 | $874 |
| 2021-12-31 | $432 |
| 2021-09-30 | $427 |
| 2021-06-30 | $412 |
| 2021-03-31 | $200 |
| 2020-12-31 | $166 |
| 2020-09-30 | $169 |
| 2020-06-30 | $172 |
| 2020-03-31 | $166 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.431B | $2.034B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
| Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
| 10x Genomics (TXG) | United States | $3.022B | 0.00 |
| Azenta (AZTA) | United States | $3.015B | 163.85 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
| Enovis (ENOV) | United States | $2.779B | 20.60 |
| Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
| Privia Health (PRVA) | United States | $2.238B | 99.26 |
| Schrodinger (SDGR) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 47.56 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Standard BioTools (LAB) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.451B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.128B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.094B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| ETAO (ETAO) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |